
GERMANY - KfW joins other VCs in backing Protagen AG
Kreditanstalt für Wiederaufbau (KfW) has joined existing lead investors MIG AG and Co KG Beteiligungsfonds 3 and S-Venture Capital Dortmund GmbH in raising EUR 1m in interim financing for protein research company Protagen AG. This is the third round of funding for the company. Protagen is a provider of products, services and software solutions for protein research. Recently, Protagen has received a BioChance Plus grant from the German government to identify biomarkers for multiple sclerosis and rheumatoid arthritis. The company is headquartered in Dortmund, and has a second office in New Jersey, US. At present, it employs a staff of 25.
Latest News
Verdane scores 5x MOIC in partial exit of Inriver to THL
Majority investment from THL Partners sees Verdane retain a minority stake in the Swedish company
CVC to buy sports nutrition specialist The Quality Group
GP to acquire majority stake via Fund VIII; German group’s founders to reinvest in the deal
DBAG to target EUR 1.3bn-EUR 1.5bn for new buyout fund next year
German GP’s new vehicle will be slightly larger than its predecessor, which is set to complete deployment in two years
Alcedo heads for June final close for Fund V
Italian GP has received EUR 230m in commitments to date for Fund V against a EUR 250m hard-cap